Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study
-
* Corresponding author: George D Kitas gd.kitas@dgoh.nhs.uk
Arthritis Research & Therapy 2009, 11:R110 doi:10.1186/ar2765
See related letter by Raterman et al., http://arthritis-research.com/content/11/5/413 and related letter by Toms et al., http://arthritis-research.com/content/11/5/414
Accesses
- Last 30 days: 100 accesses
- Last 365 days: 801 accesses
- All time: 3210 accesses